Atlas Trials

Giovanni Franchin, M.D, Ph.D

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Giovanni Franchin, M.D, Ph.D

RecordFirmDate
IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation. (NCT04933799)Giovanni Franchin, M.D, Ph.D2021-01-06

Track Giovanni Franchin, M.D, Ph.D automatically

Every clearance here is in the API, with alerts when new ones post.